PON1 and COVID-19: Serum PON1 activity is markedly decreased in COVID-19, especially in patients with comorbidities such as diabetes or cardiovascular disease [205,206,207], and the measurement of the serum levels of this enzyme has been proposed as a diagnostic marker [206].